NCT07792746 Sleep Apnea Biomarkers and Adherence to Continuous Positive Airway Pressure
| NCT ID | NCT07792746 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Clinique du Millenaire |
| Condition | Obstructive Sleep Apnea (OSA) |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2026-02-18 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2026-02-18 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Obstructive sleep apnea (OSA) is commonly assessed using the apnea-hypopnea index, although this measure does not fully reflect cardiovascular risk or the physiological impact of the disease. Emerging biomarkers, including sleep apnea-specific hypoxic burden, pulse wave amplitude drop index, and heart rate response, may provide additional information on cardiovascular vulnerability. This prospective multicenter observational study will investigate the association between these biomarkers, measured from the diagnostic sleep study, and adherence to continuous positive airway pressure (CPAP) therapy after three months. Symptoms, quality of life, clinical characteristics, and changes in biomarkers under continuous positive airway pressure will also be evaluated.
Eligibility Criteria
Inclusion Criteria: * Newly diagnosed obstructive sleep apnea with an indication for continuous positive airway pressure therapy * Age older than 18 years * Written informed consent obtained Exclusion Criteria: * Continuous positive airway pressure treatment during the preceding 3 months * Medical contraindication to continuous positive airway pressure therapy * Concomitant condition likely to affect adherence to continuous positive airway pressure, including severe cognitive impairment or an unstable psychiatric disorder
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07792746 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Obstructive Sleep Apnea (OSA). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07792746 currently recruiting?
Yes, NCT07792746 is actively recruiting participants. Contact the research team at fbughin@hotmail.com for enrollment information.
Where is the NCT07792746 trial being conducted?
This trial is being conducted at Montpellier, France.
Who is sponsoring the NCT07792746 clinical trial?
NCT07792746 is sponsored by Clinique du Millenaire. The trial plans to enroll 200 participants.